journal article·2025-10

Designing next generation of photosensitizers: recent advances in NIR-II triggered organic photodynamic nanomedicines

Qunpeng Duan, Youguang Tang, Jianfeng Feng, Sheng Li, Tangxin Xiao, Qi Wang

Dyes and Pigments· Volume 241
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (72)

Show source-provided references
1. Hybrid graphene-gold nanoparticle-based nucleic acid conjugates for cancer-specific multimodal imaging and combined therapeutics
2. Structurally simple osmium(II) polypyridyl complexes as photosensitizers for photodynamic therapy in the near infrared10.1002/anie.202218347 ↗
3. Intraligand excited states turn a ruthenium oligothiophene complex into a light-triggered ubertoxin with anticancer effects in extreme hypoxia10.1021/jacs.2c02475 ↗
4. A tumor-specific platform of peroxynitrite triggering ferroptosis of cancer cells10.1002/adfm.202208105 ↗
5. A facile, protein-derived supramolecular theranostic strategy for multimodal-imaging-guided photodynamic and photothermal immunotherapy in vivo10.1002/adma.202109111 ↗
6. Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway10.1038/s41467-023-40826-5 ↗
7. Cationic telluroviologen derivatives as type-I photosensitizers for tumor photodynamic theranostics10.1002/agt2.298 ↗
8. Tumor starvation induced spatiotemporal control over chemotherapy for synergistic therapy10.1002/smll.201803602 ↗
9. Triphenylamine flanked boron difluoride formazanate for NIR-II fluorescence imaging-guided photothermal therapy10.1016/j.dyepig.2022.110478 ↗
10. Rational design of polymethine dyes with NIR-II emission and high photothermal conversion efficiency for multimodal-imaging-guided photo-immunotherapy10.1002/adma.202210179 ↗
11. Dual-responsive triple-synergistic Fe-MOF for tumor theranostics10.1021/acsnano.2c10310 ↗
12. Heavy atom-free semiconducting polymer with high singlet oxygen quantum yield for prostate cancer synergistic phototherapy10.1039/C9QM00158A ↗
13. Single-component nanoagents with large stokes shift for high-effect phototheranostics10.1016/j.dyepig.2023.111494 ↗
14. Enzyme-responsive double-locked photodynamic molecular beacon for targeted photodynamic anticancer therapy10.1021/jacs.2c13732 ↗
15. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine10.1021/acsnano.3c00891 ↗
16. Overcoming the challenges of infrared photosensitizers in photodynamic therapy: the making of redaporfin10.1039/D3CC02283H ↗
17. From low to No O2-dependent hypoxia photodynamic therapy (hPDT): a new perspective10.1021/acs.accounts.2c00531 ↗
18. Photodynamic therapeutic effect of nanostructured metal sulfide photosensitizers on cancer treatment10.1186/s11671-022-03674-8 ↗
19. Nanoparticles in photodynamic therapy10.1021/cr5004198 ↗
20. Three birds with one stone: acceptor engineering of hemicyanine dye with NIR-II emission for synergistic photodynamic and photothermal anticancer therapy10.1002/smll.202204851 ↗
21. Multifunctional MnO2/Ag3SbS3 nanotheranostic agent for single-laser-triggered tumor synergistic therapy in the NIR-II biowindow10.1021/acsami.1c21752 ↗
22. Recent advances in the design and applications of near-infrared II responsive small molecule phototherapeutic agents10.1016/j.ccr.2024.215677 ↗
23. A versatile 980 nm excitable small molecule for short-wave infrared fluorescence imaging guided type-I photodynamic/photothermal therapy10.1016/j.snb.2025.137807 ↗
24. Confined semiconducting polymers with boosted NIR light-triggered H2O2 production for hypoxia-tolerant persistent photodynamic therapy10.1039/D4SC01609B ↗
25. FRET-engineering of organic nanoparticles for photoacoustic imaging-guided photodynamic and augmented photothermal therapy10.1016/j.snb.2023.135091 ↗
26. A “dual-source, dual-activation” strategy for an NIR-II window theranostic nanosystem enabling optimal photothermal-ion combination therapy10.1002/smll.202201179 ↗
27. Maximum emission peak over 1500 nm of organic assembly for blood-brain barrier-crossing NIR-IIb phototheranostics of orthotopic glioblastoma
28. Metal-coordinated NIR-II nanoadjuvants with nanobody conjugation for potentiating immunotherapy by tumor metabolism reprogramming10.1002/advs.202404886 ↗
29. NIR-II light activated photosensitizer with aggregation-induced emission for precise and efficient two-photon photodynamic cancer cell ablation
30. Mitochondrion-anchored photosensitizer with near infrared-I aggregation-induced emission for near infrared-II two-photon photodynamic therapy10.1002/adhm.202101056 ↗
31. Self-assembled organic nanomedicine enables ultrastable photo-to-heat converting theranostics in the second near-infrared biowindow10.1038/s41467-020-20566-6 ↗
32. Second near-infrared photothermal materials for combinational nanotheranostics10.1039/D0CS00664E ↗
33. A borondifluoride-complex-based photothermal agent with an 80 % photothermal conversion efficiency for photothermal therapy in the NIR-II window10.1002/anie.202107836 ↗
34. Conjugated-polymer-based nanomaterials for photothermal therapy10.1021/acsapm.0c00680 ↗
35. Recent advances in the design of organic photothermal agents for cancer treatment: a review10.1016/j.ccr.2024.215719 ↗
36. Rational design of biomaterials to potentiate cancer thermal therapy10.1021/acs.chemrev.2c00822 ↗
37. Manipulating host-guest charge transfer of a water-soluble double-cavity cyclophane for NIR-II photothermal therapy
38. Inhibiting osteolytic breast cancer bone metastasis by bone-targeted nanoagent via remodeling the bone tumor microenvironment combined with NIR-II photothermal therapy10.1002/smll.202301003 ↗
39. Synthesis of germanium/germanium phosphide in-plane heterostructure with efficient photothermal and enhanced photodynamic effects in the second near-infrared biowindow10.1016/j.jcis.2023.08.137 ↗
40. Effective nanocomposite based on Bi2MoO6/MoS2/AuNRs for NIR-II light-boosted photodynamic/chemodynamic therapy10.1021/acs.langmuir.3c00372 ↗
41. Molecular oligomerization and donor engineering strategies for achieving superior NIR-II fluorescence imaging and thermotherapy under 1064 nm laser irradiation
42. Photoactive oligomer with D–D′–A–D′–D′′–D′–A–D′–D scaffold for high-efficiency NIR-II phototheranostics10.1039/D3CC02199H ↗
43. Simple preparation of near-infrared-II organic small molecule-based phototheranostics by manipulation of the electron-donating unit10.6023/A22060267 ↗
44. Organic semiconducting luminophores for near-infrared afterglow, chemiluminescence, and bioluminescence imaging
45. Near-infrared-II triggered inorganic photodynamic nanomedicines for deep-tissue therapy10.1016/j.jmst.2024.07.002 ↗
46. Beyond traditional light: NIR-II light-activated photosensitizers for cancer therapy10.1039/D3TB00668A ↗
47. Bright near-infrared π-conjugated oligomer nanoparticles for deep-brain three-photon microscopy excited at the 1700 nm window in vivo10.1021/acsnano.2c03813 ↗
48. Modulating aggregation and deaggregation based on assembling strategy to switch on NIR-II light-excited fluorescence for self-reporting viability of eliminating cancer cell10.1021/acs.analchem.4c03788 ↗
49. Molecular tailoring based on forster resonance energy transfer for initiating two-photon theranostics with amplified reactive oxygen species10.1021/acs.analchem.2c03408 ↗
50. A RNA-targeted two-photon bioprobe with high selective permeability into nuclear pore complexes for dynamically tracking the autophagy process among multi-organelles10.1021/acs.analchem.9b03009 ↗
51. AIE-based theranostic agent: in situ tracking mitophagy prior to late apoptosis to guide the photodynamic therapy10.1021/acsami.9b15577 ↗
52. Coumarin-based fluorescent probes for super-resolution and dynamic tracking of lipid droplets10.1021/acs.analchem.8b04079 ↗
53. Facile protein assembly activating three-photon activity: a zig-zag lift modulated by the “odd-even” effect of alkyl chains10.1007/s40843-022-2368-3 ↗
54. NIR-II light-activated two-photon squaric acid dye with type I photodynamics for antitumor therapy10.1515/nanoph-2022-0482 ↗
55. An NIR-II two-photon excitable AIE photosensitizer for precise and efficient treatment of orthotopic small-size glioblastoma
56. GSH-activatable copper-elsinochrome off-on photosensitizer for combined specific NIR-II two-photon photodynamic/chemodynamic therapy
57. Tailored engineering of novel xanthonium polymethine dyes for synergetic PDT and PTT triggered by 1064 nm laser toward deep-seated tumors10.1002/smll.202100398 ↗
58. Development of a novel anti-tumor theranostic platform: a near-infrared molecular upconversion sensitizer for deep-seated cancer photodynamic therapy10.1039/C9SC04034J ↗
59. An NIR-II excitable AIE small molecule with multimodal phototheranostic features for orthotopic breast cancer treatment
60. High-efficiency organic semiconducting small molecule for deep-tissue phototheranostics: single 1064 nm laser triggered NIR-IIb fluorescence imaging guided type-I photodynamic/photothermal combination therapy
61. Achieving efficient NIR-II type-I photosensitizers for photodynamic/photothermal therapy upon regulating chalcogen elements10.1002/adma.202108146 ↗
62. Co-delivery of NIR-II semiconducting polymer and pH-sensitive doxorubicin-conjugated prodrug for photothermal/chemotherapy10.1016/j.actbio.2021.10.009 ↗
63. Semiconducting polymer-based nanoparticles for photothermal therapy at the second near-infrared window10.1039/C8CC07583B ↗
64. NIR-II light accelerated prodrug reduction of Pt(IV)-incorporating pseudo semiconducting polymers for robust degradation and maximized photothermal/chemo-immunotherapy10.1002/adma.202300048 ↗
65. Near-infrared-II photoacoustic imaging and photo-triggered synergistic treatment of thrombosis via fibrin-specific homopolymer nanoparticles10.1038/s41467-023-42691-8 ↗
66. Stimuli-responsive organic near-infrared photoacoustic probes10.1002/adfm.202300023 ↗
67. Targeted contrast agents and activatable probes for photoacoustic imaging of cancer10.1039/D0CS00771D ↗
68. Quinoxalineimide-based semiconducting polymer nanoparticles as an effective phototheranostic for the second near-infrared fluorescence imaging and photothermal therapy10.1021/acsami.3c06853 ↗
69. Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics10.1016/j.addr.2023.114821 ↗
70. Simultaneous enhancement of the long-wavelength NIR-II brightness and photothermal performance of semiconducting polymer nanoparticles10.1021/acsami.1c20722 ↗
71. NIR-II excitable semiconducting polymers with AIE characteristics for fluorescence-photoacoustic imaging-guided synergistic phototherapy
72. Enhancing near-infrared II photodynamic therapy with nitric oxide for eradicating multidrug-resistant biofilms in deep tissues